David A. Cory

Insider Reports History

Entity
Individual
Location
350 Cambridge Avenue, Suite 350, Palo Alto, CA
Signature
/s/ Sriram Ryali, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David A. Cory:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. President and CEO, Director Common Stock 169K $50.4K $0.30 Mar 11, 2022 Direct
Eiger BioPharmaceuticals, Inc. President and CEO, Director Stock Option (Right to Buy) 281K Mar 11, 2022 Direct

Insider Reports Filed by David A. Cory

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EIGR Eiger BioPharmaceuticals, Inc. Mar 11, 2022 2 $0 4 Mar 11, 2022 President and CEO, Director
EIGR Eiger BioPharmaceuticals, Inc. Jul 29, 2021 1 $0 4 Jul 30, 2021 President and CEO, Director